Rikard Holmdahl Selected Research

Rikard Holmdahl Research Topics

Disease

179	Arthritis (Polyarthritis) 04/2024 - 01/2002
137	Rheumatoid Arthritis 04/2024 - 02/2002
81	Experimental Arthritis 02/2024 - 05/2002
56	Inflammation (Inflammations) 04/2024 - 01/2002
39	Autoimmune Diseases (Autoimmune Disease) 04/2024 - 01/2002
12	Psoriasis (Pustulosis Palmaris et Plantaris) 06/2023 - 10/2006
9	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 05/2017 - 07/2002
7	Pain (Aches) 02/2024 - 12/2012
7	Systemic Lupus Erythematosus (Libman-Sacks Disease) 10/2023 - 09/2002
7	Neoplasms (Cancer) 01/2022 - 10/2010
6	Psoriatic Arthritis 06/2023 - 09/2016
6	Infections 12/2022 - 09/2014
6	Hypersensitivity (Allergy) 01/2022 - 08/2004
6	Multiple Sclerosis 05/2017 - 01/2003
5	Pneumonia (Pneumonitis) 01/2023 - 04/2013
5	Chronic Granulomatous Disease 12/2014 - 11/2012
4	Necrosis 01/2021 - 08/2005
4	Colitis 03/2018 - 01/2014
4	Relapsing Polychondritis 03/2004 - 01/2002
3	Osteoarthritis 11/2022 - 09/2002
3	Chronic Disease (Chronic Diseases) 05/2022 - 08/2011
3	Pathologic Processes 09/2016 - 01/2010
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2016 - 09/2011
2	Sepsis (Septicemia) 01/2023 - 07/2010

Drug/Important Bio-Agent (IBA)

93	Collagen Type II (Type II Collagen)IBA 06/2023 - 01/2002
64	AntibodiesIBA 11/2023 - 09/2002
45	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2002
41	CollagenIBA 12/2022 - 01/2002
40	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2024 - 09/2005
39	AutoantibodiesIBA 02/2024 - 09/2002
38	Peptides (Polypeptides)IBA 03/2024 - 01/2003
36	EpitopesIBA 01/2023 - 06/2002
33	pristane (pristan)IBA 01/2021 - 01/2002
27	AntigensIBA 03/2024 - 08/2005
26	Immunoglobulin G (IgG)IBA 02/2024 - 09/2002
21	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2020 - 01/2003
18	CytokinesIBA 01/2023 - 10/2002
15	AutoantigensIBA 11/2023 - 01/2002
14	Anti-Citrullinated Protein AntibodiesIBA 02/2024 - 01/2010
13	neutrophil cytosolic factor 1IBA 04/2024 - 01/2003
13	MannansIBA 06/2023 - 09/2014
13	Monoclonal AntibodiesIBA 05/2022 - 09/2002
12	acetyl 4-aminosalicylic acidIBA 01/2023 - 01/2010
11	GlycopeptidesIBA 01/2018 - 12/2002
9	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 04/2024 - 06/2002
9	Antigen-Antibody Complex (Immune Complex)IBA 11/2023 - 07/2004
9	Cartilage Oligomeric Matrix ProteinIBA 01/2022 - 01/2002
8	Polysaccharides (Glycans)IBA 12/2022 - 10/2007
8	Histocompatibility Antigens Class IIIBA 11/2012 - 01/2006
7	Rheumatoid FactorIBA 02/2024 - 12/2003
7	VaccinesIBA 01/2023 - 10/2010
7	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2022 - 12/2002
6	Immunoglobulin M (IgM)IBA 11/2023 - 12/2003
6	EnzymesIBA 11/2017 - 03/2006
5	NADPH Oxidase 2IBA 10/2023 - 05/2012
5	Amino Acids FDA Link 06/2023 - 09/2002
5	Glucose-6-Phosphate Isomerase (Phosphoglucose Isomerase)IBA 01/2023 - 01/2005
5	HLA-DRB1 Chains (HLA DRB1)IBA 01/2022 - 01/2006
5	Oxygen (Dioxygen)IBA 01/2020 - 08/2007
5	Complement System Proteins (Complement)IBA 10/2013 - 03/2004
4	B-Lymphocyte Epitopes (B-Cell Epitope)IBA 01/2023 - 08/2015
4	Therapeutic UsesIBA 01/2023 - 07/2004
4	Collagen Type XIIBA 01/2020 - 05/2002
4	Glycoproteins (Glycoprotein)IBA 01/2020 - 01/2002
4	LipopolysaccharidesIBA 01/2020 - 11/2003
4	InterferonsIBA 01/2020 - 07/2013
4	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2018 - 01/2010
4	Mineral Oil (Liquid Paraffin)FDA LinkGeneric 11/2017 - 12/2007
4	4- ethoxymethylene- 2- phenyl- 2- oxazoline- 5- one (phOx)IBA 11/2012 - 02/2007
4	NADP (NADPH)IBA 07/2012 - 09/2005
3	Cysteine (L-Cysteine)FDA Link 04/2024 - 10/2007
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 09/2013
3	glycosylated collagenIBA 01/2022 - 07/2002
3	LipidsIBA 01/2021 - 11/2017
3	LigandsIBA 10/2020 - 08/2010
3	Interleukin-17 (Interleukin 17)IBA 01/2020 - 01/2017
3	NitrogenIBA 01/2020 - 09/2009
3	SodiumIBA 03/2018 - 08/2014
3	AsparagineIBA 01/2018 - 10/2007
3	Acute-Phase Proteins (Acute-Phase Protein)IBA 11/2017 - 01/2002
3	Proteoglycans (Proteoglycan)IBA 07/2017 - 06/2011
3	Estrogens (Estrogen)FDA Link 11/2016 - 11/2003
3	PolymersIBA 01/2016 - 11/2011
3	poly-N-isopropylacrylamideIBA 01/2016 - 11/2011
3	CitrullineIBA 10/2015 - 02/2009
3	Immunodominant EpitopesIBA 11/2014 - 01/2006
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2006 - 02/2002
3	Myelin-Oligodendrocyte GlycoproteinIBA 08/2004 - 07/2002
2	Complement C5 (Complement 5)IBA 02/2024 - 09/2006
2	IgG Receptors (Fc gamma RI)IBA 02/2024 - 01/2021
2	Interleukin-10 (Interleukin 10)IBA 11/2023 - 01/2004
2	NucleotidesIBA 06/2023 - 06/2011
2	Arginine (L-Arginine)FDA Link 06/2023 - 11/2022
2	Amino Acid Transport Systems (Amino Acid Transporter)IBA 01/2023 - 12/2015
2	Mitochondrial DNA (mtDNA)IBA 01/2023 - 12/2009

Therapy/Procedure

9	Therapeutics 01/2023 - 02/2002
4	Intraperitoneal Injections 06/2023 - 09/2005
4	Injections 05/2022 - 03/2005
3	Intravenous Injections 05/2022 - 07/2004
3	Transplantation 10/2010 - 06/2002